Cardiovascular Rehabilitation for Heart Disease
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Recruiting
Sponsor: Laval University
No Placebo Group
Approved in 2 jurisdictions
Trial Summary
What is the purpose of this trial?The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).
Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.
Is the treatment Cardiovascular Rehabilitation Program a promising treatment for heart disease?Yes, the Cardiovascular Rehabilitation Program is a promising treatment for heart disease. It helps improve the quality of life for patients by reducing the risk of future heart problems, supporting a return to normal activities like work, and promoting healthy lifestyle habits such as regular physical activity.1691011
What safety data exists for cardiovascular rehabilitation for heart disease?Cardiovascular rehabilitation, also known as cardiac rehabilitation, has been shown to significantly reduce total mortality, myocardial infarction, and hospitalization in patients with heart disease, as evidenced by cohort studies involving over 10,000 patients. It is recommended by medical societies for various heart conditions, including heart failure and post-surgery recovery. The programs are well-established and improve prognosis by controlling cardiovascular risk factors, enhancing quality of life, and reducing further events. However, future evaluations through randomized controlled trials are suggested to tailor interventions to specific patient subgroups.4781112
What data supports the idea that Cardiovascular Rehabilitation for Heart Disease is an effective treatment?The available research shows that Cardiovascular Rehabilitation for Heart Disease is effective because it improves the quality of life and reduces the risk of future heart problems. It helps control risk factors like high blood pressure and cholesterol, which can lead to fewer heart-related events. Studies also indicate that it decreases mortality rates, meaning people who participate in these programs tend to live longer. Compared to other treatments, it is recommended as part of comprehensive care for heart disease patients, emphasizing the importance of regular physical activity and healthy lifestyle habits.235611
Do I have to stop taking my current medications for this trial?The trial protocol does not specify whether you need to stop taking your current medications.
Eligibility Criteria
This trial is for individuals with various heart and blood vessel conditions like coronary artery disease, stroke, or peripheral arterial disease. Participants should be referred to a 12-week cardiovascular rehabilitation program.Inclusion Criteria
I am 18 or older with a diagnosis of heart or artery disease.
Exclusion Criteria
I am unable to provide written consent.
Treatment Details
The study aims to observe changes in blood flow in the forefoot of patients with vascular diseases after they complete a specialized 12-week heart health improvement program.
1Treatment groups
Experimental Treatment
Group I: Cardiovascular rehabilitation programExperimental Treatment1 Intervention
Cardiovascular Rehabilitation Program is already approved in European Union, United States for the following indications:
🇪🇺 Approved in European Union as Cardiovascular Rehabilitation Program for:
- Coronary artery disease
- Heart failure
- Peripheral arterial disease
- Post-myocardial infarction rehabilitation
🇺🇸 Approved in United States as Cardiac Rehabilitation Program for:
- Coronary artery disease
- Heart failure
- Peripheral arterial disease
- Post-myocardial infarction rehabilitation
Find a clinic near you
Research locations nearbySelect from list below to view details:
CLSC de Lévis - Programme PREV du CISSS de Chaudière-AppalachesLévis, Canada
Loading ...
Who is running the clinical trial?
Laval UniversityLead Sponsor
CISSS de Chaudière-AppalachesCollaborator
References
The challenge of cardiac rehabilitation. [2016]Cardiac rehabilitation has emerged as an integral part of cardiovascular care and an important and exciting area of rehabilitation. Its future will depend on the maintenance of adequate funding sources and demonstration that quality of life or cost/benefit assessments justify the continuance of such programs. Physical activity will remain as the cornerstone of most programs, but it must be integrated with other risk factor modification programs. The practitioner of cardiac rehabilitation will need to recognize the appropriate application of risk factor modification.
[Effects of inpatient rehabilitation on cardiovascular risk factors in patients with coronary heart disease. PIN-Study Group]. [2006]The prognostically favourable effect of secondary prevention in patients with proven coronary heart disease (CHD: documented myocardial infarction, angiographically proven coronary artery stenosis > 60% and/[or] status after coronary artery surgery) has been demonstrated. But it has not been adequately shown to what extent the guidelines laid down by specialist societies is being followed in routine clinical practice. Nor have there been any large-size standardized investigations of whether in-hospital rehabilitation decreases cardiovascular risk factors. It was the aim of this study to investigate the acute effects on cardiovascular risk factors of in-hospital post-infarction rehabilitation.
Cardiac rehabilitation secondary prevention programs. [2019]Contemporary cardiac rehabilitation programs are more accurately described as "secondary prevention centers." They offer comprehensive care for the patient with cardiovascular disease, resulting in decreased mortality, improvement of most cardiac risk factors, and an enhanced quality of life. Although overall participation has increased with enhanced recognition of the importance of secondary prevention, 80% of eligible patients still do not participate, in part due to lack of insurance reimbursement. This rate can be significantly increased by specific endorsement from the physician.
Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. [2008]Cardiac rehabilitation (CR)/secondary prevention programming is dependent on clinical attributes of participants. We examined recent changes in the profile of individuals who are entering CR.
[Impact of cardiac rehabilitation programs on coronary risk profile]. [2008]Rehabilitation and secondary prevention in patients with cardiovascular disease impact positively on their mortality, morbility, economy and quality of life. In addition, they are a coadjuvant to the medical programs to treatment even in high risk patients. It is advisable to cardiologists that in their medical practice, advise to their low risk patients, on physical activity as a secondary prevention measure. In those high risk patients is better to refer them to expert hands.
Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity. [2009]Cardiac rehabilitation/secondary prevention programs are recognized as integral to the comprehensive care of patients with coronary heart disease, and as such are recommended in most contemporary clinical practice guidelines. The interventions are aimed at reducing disability, optimizing cardiovascular risk reduction by drug therapy and promoting healthy behavior. Healthy lifestyle habits must be recognized as capable of substantially reducing the risk for cardiovascular events in patients with coronary heart disease. This review highlights the recommended components of cardiac rehabilitation/secondary prevention programs, with special emphasis on regular physical activity.
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. [2022]Increasing awareness of the importance of cardiovascular prevention is not yet matched by the resources and actions within health care systems. Recent publication of the European Commission's European Heart Health Charter in 2008 prompts a review of the role of cardiac rehabilitation (CR) to cardiovascular health outcomes. Secondary prevention through exercise-based CR is the intervention with the best scientific evidence to contribute to decrease morbidity and mortality in coronary artery disease, in particular after myocardial infarction but also incorporating cardiac interventions and chronic stable heart failure. The present position paper aims to provide the practical recommendations on the core components and goals of CR intervention in different cardiovascular conditions, to assist in the design and development of the programmes, and to support healthcare providers, insurers, policy makers and consumers in the recognition of the comprehensive nature of CR. Those charged with responsibility for secondary prevention of cardiovascular disease, whether at European, national or individual centre level, need to consider where and how structured programmes of CR can be delivered to all patients eligible. Thus a novel, disease-oriented document has been generated, where all components of CR for cardiovascular conditions have been revised, presenting both well-established and controversial aspects. A general table applicable to all cardiovascular conditions and specific tables for each clinical disease have been created and commented.
[Cardiovascular rehabilitation]. [2021]Cardiovascular rehabilitation encompasses the optimization of secondary prevention to reduce morbidity and mortality, the improvement of physical fitness and quality of life as well as the reintegration into social life and employment. This requires a multifactorial intervention on the physical, psychological, educative and social level by a multidisciplinary team. In Germany, cardiac rehabilitation started early after an index event, could demonstrate a significant reduction of total mortality, myocardial infarction and hospitalization during a follow-up of 1-2 years in 4 cohort studies including 10,758 patients with myocardial infarction and bypass surgery. This reduction of clinical events was obtained in addition to rapid revascularization therapy during the acute coronary event and on top of an evidence based secondary preventive medication. By national and international medical societies, cardiac rehabilitation is recommended as well in patients with congestive heart failure, after valve replacement or valve repair, after heart transplantation and cardioverter/defibrillator implantation. In the future, cardiac rehabilitation in Germany should be evaluated by a randomized controlled trial and multifactorial interventions should be tailored individually to specific patient subgroups and medical conditions.
Quality service delivery in cardiac rehabilitation: cross-cultural challenges in an Australian setting. [2016]Cardiac rehabilitation is an evidence-based health service model for providing secondary prevention strategies following an acute cardiac event. In spite of the benefits of cardiac rehabilitation, there are striking cultural and ethnic disparities with regard to access to and usage of these programmes.
[Return to work in patients with heart disease after cardiac rehabilitation]. [2017]Cardiac rehabilitation is a secondary prevention strategy which it includes a set of activities that would assure cardiac patients a place as normal as it could be into the society, being also essential for going back to work, by improving their quality of life and reducing costs for institutions.
[Cardiovascular rehabilitation - a current overview]. [2020]Cardiovascular rehabilitation - a current overview Abstract. Cardiovascular rehabilitation is a well established part of the treatment of patients after acute cardiovascular events and after heart surgery. Cardiac rehabilitation programs improve the prognosis after acute coronary syndroms through reducing further events by a better control of cardiovascular risk factors and thus granting the participants a better quality of life. Due to the evidence of the cardiovascular prevention research of the past 20 years rehabilitation has become part of the recommendations of the guidelines. The following article presents an overview of the established methods an indications of rehabilitation in times of progress in interventional techniques and better medical treatment options.
Nurse-led and Interdisciplinary Secondary Cardiovascular Prevention Programmes: Spanish Cohort of the EUROACTION Project. [2022]Cardiovascular prevention and rehabilitation programmes (CVPRP) are a preventive tool, which can reverse unhealthy behaviours and improve risk factor management. They have been successfully implemented in a variety of settings in patients with coronary heart disease (CHD).